Bloom Surgical: 2025 Year In Review
2025 marked a year of significant progress of reached milestones and successes for Bloom Surgical […]
Category: BioUtah News
Adam Barker, PhD, Named President and Chief Operations Officer of ARUP Reference Business Unit
A microbiologist, Adam Barker, PhD, was ARUP’s chief scientific officer and director of Research and Development before being named chief operations officer—now adds Reference Business Unit president to his title. […]
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
The Australian patent represents the first patent granted for the Company’s new point-of-care testing platform. […]
Merit Medical’s Fred Lampropoulos Honored by Nasdaq
Merit Medical’s Fred Lampropoulos Honored by Nasdaq […]
Perimeter Solutions Announces Agreement to Acquire MMT for $685 Million
Perimeter Solutions Announces Agreement to Acquire MMT for $685 Million […]
Freyya Recognized at Transatlantic Angel Competition (TAAC8)
Freyya Recognized at Transatlantic Angel Competition (TAAC8) […]
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India […]
Owlet Announces New DME Partnership With 1 Natural Way to Expand Insurance-Supported Access to BabySat® Infant Pulse Oximeter
Collaboration expands Owlet’s national DME footprint, strengthens access for Medicaid and TRICARE families, and supports continued growth in prescription-backed revenue channel. […]
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
In-vitro studies confirmed strong uptake of cell-targeting nanoparticles by cancer cells and strong activation of Smart mRNAs inside cancer cells […]
Peel Therapeutics CEO Joshua Schiffman Presents at CureCRC Summit
Peel Therapeutics CEO Joshua Schiffman Presents at CureCRC Summit […]
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas […]
Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History
Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History […]